While S&P 500 is at its all-time high, Danaher is still ~34% below its peak from late 2021. The company was beleaguered with ...

In this piece, we will look at the stocks Jim Cramer recently discussed.

In-Vitro Diagnostics Market 2025 IVD market set to grow at 5.0% CAGR to 2032, fueled by chronic disease demand, tech advances, and billion- ...

Contract research organizations are reporting better-than-expected second-quarter profit, a sign that Wall Street analysts ...

Acting Columbia president speaks out after $220 million settlement with Trump admin. CCTV Footage Captures the First-Ever ...

The global drug of abuse testing market size is expected to be worth over USD 23.05 billion by 2034 from USD 14.67 billion in ...

Overview of Therapeutic Drug Monitoring MarketThe Global Therapeutic Drug Monitoring Market is valued at USD 2.5 Billion in ...

Overview of Companion Diagnostics MarketThe Companion Diagnostics Market is evolving rapidly, driven by the growing demand ...

Investors interested in Medical Services stocks are likely familiar with CVS Health (CVS) and Danaher (DHR). But which of these two stocks is more attractive to value investors? We'll need to take a ...